SP

Shailesh Pandurang Rane

Active Director Director DIN 05229925
DIN 05229925 First appointment Apr 2012 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailesh Pandurang Rane

Data last updated:

Shailesh Pandurang Rane is a Director at Jbs Pharma Chem Private Limited (since 2012). The company operates in Chemicals.

DIN 05229925
Primary Designation Director
Industry Chemicals
First Appointment 03 Apr 2012
Oldest Company Age 14 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jbs Pharma Chem Private Limited U24233MH2012PTC229182
Director03 Apr 20122012Active

Board colleagues of Shailesh Pandurang Rane

Directorship timeline

Open interactive timeline →
Jbs Pharma Chem Private Limited
Premium access

Shareholding and investment profile for Shailesh Pandurang Rane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Pandurang Rane

Shailesh Pandurang Rane currently holds 1 directorship: Jbs Pharma Chem Private Limited (Director, since 03 Apr 2012).

Shailesh Pandurang Rane was first appointed on 03 Apr 2012 as Director at Jbs Pharma Chem Private Limited.

The current boards of Shailesh Pandurang Rane's companies include Bhaskar Baburuhah Berad (Jbs Pharma Chem Private Limited), Josseph Edward Fernandesz (Jbs Pharma Chem Private Limited), Sanjay Shankarrao Nehere (Jbs Pharma Chem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available